388 related articles for article (PubMed ID: 10951333)
1. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
[TBL] [Abstract][Full Text] [Related]
2. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of mucin phenotype, beta-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma.
Aihara R; Mochiki E; Nakabayashi T; Akazawa K; Asao T; Kuwano H
Br J Surg; 2005 Apr; 92(4):454-62. PubMed ID: 15609380
[TBL] [Abstract][Full Text] [Related]
4. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
[TBL] [Abstract][Full Text] [Related]
5. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma.
Nakamura T; Yao T; Kabashima A; Nishiyama K; Maehara Y; Tsuneyoshi M
Histopathology; 2005 Oct; 47(4):357-67. PubMed ID: 16178890
[TBL] [Abstract][Full Text] [Related]
6. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype.
Watari J; Saitoh Y; Fujiya M; Shibata N; Tanabe H; Inaba Y; Okamoto K; Maemoto A; Ohta T; Yasuda A; Ayabe T; Ashida T; Yokota K; Obara T; Kohgo Y
J Gastroenterol; 2004; 39(2):104-12. PubMed ID: 15069616
[TBL] [Abstract][Full Text] [Related]
7. Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas.
Kawachi H; Takizawa T; Eishi Y; Shimizu S; Kumagai J; Funata N; Koike M
J Pathol; 2003 Apr; 199(4):436-46. PubMed ID: 12635134
[TBL] [Abstract][Full Text] [Related]
8. Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype.
Motoshita J; Nakayama H; Taniyama K; Matsusaki K; Yasui W
Pathol Int; 2006 Apr; 56(4):200-5. PubMed ID: 16634965
[TBL] [Abstract][Full Text] [Related]
9. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
Sasaki A; Kitadai Y; Ito M; Tanaka S; Yoshihara M; Haruma K; Chayama K
Oncology; 2004; 66(5):379-87. PubMed ID: 15331925
[TBL] [Abstract][Full Text] [Related]
10. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.
Shiroshita H; Watanabe H; Ajioka Y; Watanabe G; Nishikura K; Kitano S
Pathol Int; 2004 May; 54(5):311-21. PubMed ID: 15086835
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications.
Lee OJ; Kim HJ; Kim JR; Watanabe H
Oncol Rep; 2009 Feb; 21(2):387-93. PubMed ID: 19148512
[TBL] [Abstract][Full Text] [Related]
13. Correlation between cyclooxygenase-2, proliferative activity, and mucin phenotype in human advanced gastric cancer.
Yamagishi M; Noda M; Tatsumi Y; Mukaisho K; Mitsufuji S; Sugihara H; Okanoue T; Hattori T
J Gastroenterol; 2004 Dec; 39(12):1143-9. PubMed ID: 15622477
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of E-cadherin, beta-catenin and gamma-catenin gene expression with the invasion and metastasis of gastric carcinoma].
Wang CX; Chen J; Yang Z; Song W; Du ZL; Li ZH
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1198-201. PubMed ID: 14625188
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of beta-catenin and c-erbB-2 in early gastric cancer.
Ougolkov A; Mai M; Takahashi Y; Omote K; Bilim V; Shimizu A; Minamoto T
J Exp Clin Cancer Res; 2000 Sep; 19(3):349-55. PubMed ID: 11144528
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival].
Zhou YN; Li M
Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis.
Yi Kim D; Kyoon Joo J; Kyu Park Y; Yeob Ryu S; Soo Kim H; Kyun Noh B; Hwa Lee K; Hyuk Lee J
J Surg Oncol; 2007 Oct; 96(5):429-35. PubMed ID: 17786966
[TBL] [Abstract][Full Text] [Related]
19. Malignant potential regarding mucin phenotypes and endocrine cell differentiation in gastric adenocarcinoma.
Naritomi K; Futami K; Arima S; Iwashita A
Anticancer Res; 2003; 23(6a):4411-22. PubMed ID: 14666728
[TBL] [Abstract][Full Text] [Related]
20. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]